Page last updated: 2024-10-26

valproic acid and Rubinstein-Taybi Syndrome

valproic acid has been researched along with Rubinstein-Taybi Syndrome in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Rubinstein-Taybi Syndrome: A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with deletions of the short arm of chromosome 16 (16p13.3).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hellings, JA1
Hossain, S1
Martin, JK1
Baratang, RR1

Reviews

1 review available for valproic acid and Rubinstein-Taybi Syndrome

ArticleYear
Psychopathology, GABA, and the Rubinstein-Taybi syndrome: a review and case study.
    American journal of medical genetics, 2002, Mar-08, Volume: 114, Issue:2

    Topics: Adult; Chromosome Deletion; Chromosomes, Human, Pair 16; Female; GABA Agonists; Humans; Mental Disor

2002